SCHEMBL27703278

SCHEMBL27703278

CCCC(=O)ON1C(=O)C(=O)c2cc(Cl)ccc21

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH3A1 P30838 6/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ ALDH2 P05091 3/20 0.43
▸ UCHL3 P15374 1/20 0.38
▸ UCHL1 P09936 1/20 0.38
▸ GABRA1 P14867 1/20 0.38
▸ GABRG2 P18507 1/20 0.38
▸ GABRB3 P28472 1/20 0.38
▸ GABRA5 P31644 1/20 0.38
▸ GABRA3 P34903 1/20 0.38
▸ GABRA2 P47869 1/20 0.38
▸ GABRA6 Q16445 1/20 0.38
▸ CES1 P23141 1/20 0.38
▸ AGTR1 P30556 1/20 0.37
▸ TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28476821 0.85 ALDH1A1 (0.55) ALDH1A1CES1AGTR1
SCHEMBL27723886 0.81 CES1 (0.58) ALDH3A1ALDH1A1ALDH2CES1AGTR1
SCHEMBL27703282 0.74 CES1 (0.38) ALDH1A1CES1
SCHEMBL10568960 0.71 ALDH1A1 (0.48) ALDH3A1ALDH1A1ALDH2GABRA1GABRG2
SCHEMBL27703276 0.71 ALDH1A1 (0.76) ALDH3A1ALDH1A1ALDH2TSHR
SCHEMBL2373229 0.71 CES1 (0.63) ALDH3A1ALDH1A1ALDH2CES1AGTR1
SCHEMBL11959135 0.70 ALDH1A1 (0.56) ALDH3A1ALDH1A1ALDH2CES1AGTR1
SCHEMBL18954676 0.70 ALDH1A1 (0.56) ALDH3A1ALDH1A1ALDH2GABRA1GABRG2
SCHEMBL16048101 0.70 ALDH3A1 (0.65) ALDH3A1ALDH1A1ALDH2
SCHEMBL11369567 0.70 S100A4 (0.47) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103271906-A Use of spiro-oxindole compounds as therapeutic agents XENON PHARMACEUTICALS INC 2013-09-04 — — CN disclosed
CN-102153562-A Spiro-oxindole compounds and their uses as therapeutic agents XENON PHARMACEUTICALS INC 2011-08-17 — — CN disclosed
CN-101631546-A Use of spiro-indolone compounds as therapeutic agents XENON PHARMACEUTICALS INC 2010-01-20 — — CN disclosed
CN-101213174-A Oxindole compounds and their uses as therapeutic agents XENON PHARMACEUTICALS INC (CA) 2008-07-02 — — CN disclosed
CN-101184761-A Spiro-indolone compounds and their use as therapeutic agents XENON PHARMACEUTICALS INC (CA) 2008-05-21 — — CN disclosed
Send feedback